Simon, Dagmar; Lübbe, Jann; Wüthrich, Brunello; Wiesner, Alice; Weber, M Monika; Laffitte, Emmanuel; Anliker, Mark D; Schöni, Martin H; Braathen, Lasse R; Schmid-Grendelmeier, Peter; Gilgen Bobalj, Nicole; Schneider, Dirk (2006). Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort. Dermatology, 213(4), pp. 313-8. Basel: Karger 10.1159/000096195
|
Text
000096195.pdf - Published Version Available under License Publisher holds Copyright. Download (246kB) | Preview |
BACKGROUND: Controlled studies established the efficacy and good tolerability of pimecrolimus cream 1% for the treatment of atopic dermatitis but they may not reflect real-life use. OBJECTIVE: To evaluate the efficacy, tolerability and cosmetic acceptance of a pimecrolimus-based regimen in daily practice in Switzerland. METHODS: This was a 6-month, open-label, multicentre study in 109 patients (55% > or = 18 years) with atopic dermatitis. Pimecrolimus cream 1% was incorporated into patients' standard treatment protocols. RESULTS: The pimecrolimus-based treatment was well tolerated and produced disease improvement in 65.7% of patients. It was particularly effective on the face (improvement rate: 75.0%). Mean pimecrolimus consumption decreased from 6.4 g/day (months 1-3) to 4.0 g/day (months 3-6) as disease improved. Most patients (74.1%) rated their disease control as 'complete' or 'good' and 90% were highly satisfied with the cream formulation. CONCLUSION: The use of a pimecrolimus-based regimen in everyday practice was effective, well tolerated and well accepted by patients.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology |
UniBE Contributor: |
Simon, Dagmar, Braathen, Lasse Roger |
ISSN: |
1018-8665 |
ISBN: |
17135737 |
Publisher: |
Karger |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:46 |
Last Modified: |
21 Jun 2023 12:06 |
Publisher DOI: |
10.1159/000096195 |
PubMed ID: |
17135737 |
Web of Science ID: |
000242372000008 |
BORIS DOI: |
10.48350/18892 |
URI: |
https://boris.unibe.ch/id/eprint/18892 (FactScience: 1158) |